Skip to main content

From the histological to the mutational model. The President position

By 27 Settembre 2019Maggio 14th, 2021No Comments

Advancing of knowledge in cancer molecular profiling has lead to an increasingly complex diagnostic classification, with several tumors types that are now divided in specific subtypes based on their genomic characteristics. According to ESMO President Josep Tabernero, this highlights the need to invest in properly diagnosing the patients, in order to provide them the best treatment solutions, and in physicians education about genetic profiling.